D J Koehn Consulting Services Inc. | |
8359 Beacon Blvd Ste 301 Fort Myers FL 33907-3059 | |
(571) 309-7993 | |
(800) 387-5701 |
Full Name | D J Koehn Consulting Services Inc. |
---|---|
Speciality | Behavior Analyst |
Location | 8359 Beacon Blvd Ste 301, Fort Myers, Florida |
Authorized Official Name and Position | David James Koehn (PRESIDENT) |
Authorized Official Contact | 5713097993 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
D J Koehn Consulting Services Inc. Po Box 6552 Sheridan WY 82801-7100 Ph: (571) 309-7993 | D J Koehn Consulting Services Inc. 8359 Beacon Blvd Ste 301 Fort Myers FL 33907-3059 Ph: (571) 309-7993 |
NPI Number | 1003329632 |
---|---|
Provider Enumeration Date | 11/06/2017 |
Last Update Date | 11/06/2020 |
Certification Date | 11/06/2020 |
Medicare PECOS PAC ID | 5597024653 |
---|---|
Medicare Enrollment ID | O20180117002144 |
News Archive
In this Guardian opinion piece, the newspaper's health editor, Sarah Boseley, responds to the positive results of a large-scale clinical trial of an experimental malaria vaccine reported on Tuesday and recaps other strides made against the disease in recent years, writing that "there is a way to go yet, with more results from the trial to come, and many uncertainties, including how much this vaccine will cost and who will be persuaded to pay."
Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.
The Associated Press/KLAS-TV in Las Vegas: "The Nevada attorney general's office has filed a federal antitrust lawsuit against a $3.1 billion health care merger it says would reduce competition for psychiatric care in Las Vegas. ... The lawsuit is aimed at a proposed merger between Universal Health Services Inc. and Psychiatric Solutions Inc."
UAlberta chemistry professor Robert Campbell is developing new ways to see and manipulate the activity of neurons in the brain, which could revolutionize the way we understand the organ that controls most of the activities of the body.
› Verified 6 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1003329632 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
103TC0700X | Psychologist - Clinical | (* (Not Available)) | Secondary |
Provider Name | David J Koehn |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1700217429 PECOS PAC ID: 4385866813 Enrollment ID: I20141117001097 |
News Archive
In this Guardian opinion piece, the newspaper's health editor, Sarah Boseley, responds to the positive results of a large-scale clinical trial of an experimental malaria vaccine reported on Tuesday and recaps other strides made against the disease in recent years, writing that "there is a way to go yet, with more results from the trial to come, and many uncertainties, including how much this vaccine will cost and who will be persuaded to pay."
Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.
The Associated Press/KLAS-TV in Las Vegas: "The Nevada attorney general's office has filed a federal antitrust lawsuit against a $3.1 billion health care merger it says would reduce competition for psychiatric care in Las Vegas. ... The lawsuit is aimed at a proposed merger between Universal Health Services Inc. and Psychiatric Solutions Inc."
UAlberta chemistry professor Robert Campbell is developing new ways to see and manipulate the activity of neurons in the brain, which could revolutionize the way we understand the organ that controls most of the activities of the body.
› Verified 6 days ago
Provider Name | Nelson Lloyd Hadler |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1952748980 PECOS PAC ID: 6103253976 Enrollment ID: I20200218000949 |
News Archive
In this Guardian opinion piece, the newspaper's health editor, Sarah Boseley, responds to the positive results of a large-scale clinical trial of an experimental malaria vaccine reported on Tuesday and recaps other strides made against the disease in recent years, writing that "there is a way to go yet, with more results from the trial to come, and many uncertainties, including how much this vaccine will cost and who will be persuaded to pay."
Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.
The Associated Press/KLAS-TV in Las Vegas: "The Nevada attorney general's office has filed a federal antitrust lawsuit against a $3.1 billion health care merger it says would reduce competition for psychiatric care in Las Vegas. ... The lawsuit is aimed at a proposed merger between Universal Health Services Inc. and Psychiatric Solutions Inc."
UAlberta chemistry professor Robert Campbell is developing new ways to see and manipulate the activity of neurons in the brain, which could revolutionize the way we understand the organ that controls most of the activities of the body.
› Verified 6 days ago
News Archive
In this Guardian opinion piece, the newspaper's health editor, Sarah Boseley, responds to the positive results of a large-scale clinical trial of an experimental malaria vaccine reported on Tuesday and recaps other strides made against the disease in recent years, writing that "there is a way to go yet, with more results from the trial to come, and many uncertainties, including how much this vaccine will cost and who will be persuaded to pay."
Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.
The Associated Press/KLAS-TV in Las Vegas: "The Nevada attorney general's office has filed a federal antitrust lawsuit against a $3.1 billion health care merger it says would reduce competition for psychiatric care in Las Vegas. ... The lawsuit is aimed at a proposed merger between Universal Health Services Inc. and Psychiatric Solutions Inc."
UAlberta chemistry professor Robert Campbell is developing new ways to see and manipulate the activity of neurons in the brain, which could revolutionize the way we understand the organ that controls most of the activities of the body.
› Verified 6 days ago
Fort Myers Psychology, Pa Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 12791 World Plaza Ln Bldg 89, Fort Myers, FL 33907 Phone: 239-829-5494 Fax: 239-645-4777 | |
Neuropsychiatric Research Center Of Southwest Florida Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14271 Metropolis Ave, Suite A, Fort Myers, FL 33912 Phone: 239-939-7777 Fax: 239-936-0036 | |
Hope Community Wellness Center Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6238 Presidential Ct # Crt 7/8, Fort Myers, FL 33919 Phone: 863-233-9190 | |
Health Planning Council Of Southwest Florida, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8961 Daniels Center Dr Ste 401, Fort Myers, FL 33912 Phone: 239-433-6700 | |
Nest Academy & Therapy Center Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4755 Summerlin Rd Ste 4, Fort Myers, FL 33919 Phone: 786-382-5779 | |
Gables Rehab Center Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3049 Cleveland Ave Ste 145, Fort Myers, FL 33901 Phone: 786-641-1312 |